Cargando…
Autophagic and Apoptotic Effects of HDAC Inhibitors on Cancer Cells
Because epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and the promotion of tumorigenesis in cancers, novel compounds endowed with histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. Indeed, the potential of HDAC inhi...
Autor principal: | Rikiishi, Hidemi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100649/ https://www.ncbi.nlm.nih.gov/pubmed/21629704 http://dx.doi.org/10.1155/2011/830260 |
Ejemplares similares
-
Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
por: Rikiishi, Hidemi
Publicado: (2010) -
Novel Insights into the Interplay between Apoptosis and Autophagy
por: Rikiishi, Hidemi
Publicado: (2012) -
Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma
por: Trejo-Solís, Cristina, et al.
Publicado: (2018) -
HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses
por: Bolden, J E, et al.
Publicado: (2013) -
Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development
por: Jain, Mayur V, et al.
Publicado: (2013)